Basal C-reactive protein (CRP) is a heritable trait associated with long-term cardiovascular disease risk. Existing studies leave ambiguity over the key functional polymorphisms and fail to adjust for trans-acting effects. In a novel cohort of 285 Filipino systemic lupus erythematosus probands and their first-degree relatives, we quantified serum CRP and typed a dense map of CRP single-nucleotide polymorphisms (SNPs), along with SNPs in the interleukin-1b, interleukin-6 and apolipoprotein E genes. Ten CRP SNPs demonstrated association with basal CRP in a regression model (P ¼ 0.011-0.002). These delineated two haplotypes associated with high and low basal CRP expression (P ¼ 0.002). Differences in allele frequency were seen compared with Caucasian populations, enabling us to argue for an independent genetic effect from a phylogenetically distinct haplotype tagged by SNP rs1800947. We demonstrated an association between Apo e2 and higher basal CRP. Interleukin-6 genotype was associated with basal CRP, highlighting a role for acute-phase cytokines even in basal expression. Identifying these trans-acting variants may improve the use of basal CRP as a predictor cardiovascular risk, and increase our power to detect associations between CRP and disease.
Introduction
C-reactive protein (CRP) is a key component of the human acute-phase response to infection or inflammation. CRP is also expressed at low level (typically o10 mg l À1 ) in apparently healthy individuals; the so-called basal CRP. 1 Whether this low level CRP reflects subclinical inflammatory activity or whether CRP is constitutively expressed under the influence of other pathways has yet to be determined. Multiple studies have shown that basal CRP is an independent predictor of long-term cardiovascular risk, although the mechanism for this remains uncertain. 2 Whether or not CRP turns out to have a causal role in cardiovascular disease, it does have potential as a biomarker for cardiovascular risk stratification. 3 There is a strong genetic component to basal CRP expression, with authors reporting heritability in the order of 20-50%. [4] [5] [6] [7] Identifying these genetic factors may improve the ability of basal CRP to predict cardiovascular risk and, if CRP has a true causal role, identify candidates for the disease itself. CRP dysregulation may also have a role in systemic lupus erythematosus (SLE). CRP binds apoptotic cells, ribonucleoproteins and chromatin-histone complexes and potentially reduces the availability of nuclear autoantigens, perhaps by promoting complementmediated clearance. [8] [9] [10] Patients with active SLE seem unable to generate high levels of CRP typically associated with infection; however, they remain able to generate basal range CRP, and the link between basal CRP and cardiovascular disease is preserved. 11, 12 Several studies have reported the effect of CRP singlenucleotide polymorphisms (SNPs) and haplotypes on CRP expression in Caucasian populations, and a general pattern of haplotypes associated with high and low basal CRP is emerging. [13] [14] [15] [16] Single SNP analysis has proven more complicated, with SNPs tagging each of the highor low-CRP haplotypes having variously being significantly associated with basal CRP. The selection of potentially functional candidates is therefore difficult. Explanations for this inconsistency may include cohort heterogeneity resulting in subtle differences in allele frequency and effect (and hence power to detect association), or failure to adequately control for transacting genetic influences.
Databases of genotype information, such as that collated by the International HapMap Project (http:// www.hapmap.org), have revealed significant differences in both allele frequency and haplotype structure between ethnic populations. By studying non-Caucasian populations, we therefore have the potential to strengthen evidence for SNP association where SNP frequency is higher, while different patterns of recombination may eliminate SNPs as functional candidates. A number of trans-acting genetic effects on CRP expression have been reported, most notably, variation at the acute-phase cytokine genes, interleukin-6 (IL6) and interleukin-1b (IL1B), and also apolipoprotein E (APOE). 4, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] No large-scale CRP analysis has incorporated genetic data from these other loci, and we therefore aimed to examine this further in the current study.
Results
The final cohort with complete serum CRP and genotype data consisted of 285 Filipino SLE probands along with 288 unaffected family members. The median CRP was 1.88 mg l À1 (range: 0.19-203.05). Because it has yet to be determined whether basal and acute-phase CRP expression are regulated by the same genetic factors, we excluded all individuals with a CRP410 mg l À1 from further analysis. Therefore, the final basal CRP cohort contained 509 individuals with a median CRP of 1.50 mg l
À1
. The mean age was 38.2 years, 79% were women and 47% had SLE. In an initial regression model, we evaluated the effect of age, sex and SLE affection on ln-adjusted basal CRP, while incorporating a random effects factor to allow for clustering of CRP levels within families. Basal CRP increased with age (b-coefficient (b) ¼ 0.015, s.e. ¼ 0.005, t-statistic (t) ¼ 3.226, P-value (P) ¼ 0.006), and was higher in women (b ¼ 0.334, s.e. ¼ 0.145, t ¼ 2.295, P ¼ 0.023) and patients with SLE (b ¼ 0.286, s.e. ¼ 0.139, t ¼ 2.059, P ¼ 0.041). These three factors were therefore included as covariates in all subsequent regression models.
CRP genetic architecture
Nineteen CRP SNPs passed quality control checks and were included for analysis (Table 1 ). Figure 1 demonstrates the CRP haplotype structure, with haplotypes labelled F1 to F7 in order of frequency. Between rs16842502 and rs7553007, four haplotypes occur with frequency 45%. Downstream SNPs rs2592887 and rs12093699 were not contained within this haplotype block. Figure 2 shows the most likely phylogenetic relationship between these haplotypes on the basis of maximum parsimony for the mutational steps. A simple clade structure was predicted with no mutations duplicated on different branches of the tree. Haplotype F1 had the highest outgroup weighting (0.33) and was therefore proposed as the ancestral haplotype.
Cis-acting effects on basal CRP expression Each SNP within the CRP haplotype block was tested for association with basal CRP in a regression model. Age, Filipino CRP genetics B Rhodes et al rs3091244 (C vs A/T), rs3093077 and rs16842502, therefore demonstrated a strong association with basal CRP expression, with the rare allele associated with higher CRP. As we will discuss later, it is possible to argue for an independent genetic effect arising from rs1800947, or a SNP in strong linkage disequilibrium (LD) with it. We therefore repeated the analysis including rs1800947 as an independent covariate. These results are shown in the right hand columns of Table 2 . A highly significant association with basal CRP was then also seen for rs2027471, rs17860488, rs2794520 and rs2808628 with weaker effects for rs7553007, rs1205 and rs1935193. The minor allele of each of these SNPs was associated with higher basal CRP. It was notable that the inclusion of rs1800947 as a covariate increased the significance of all the associated SNPs. In addition, rs1800947 itself demonstrated a greater significance with basal CRP when modelled with another independently associated SNP; the minor allele being associated with higher basal CRP (for example, if modelled with rs3093077 the regression parameters for rs1800947 were
Haplotype analysis was run for the five commonest CRP haplotypes; the full regression model, also showing the covariate parameters, is presented in Table 3 . There is clearly a significant difference in basal CRP levels associated with commonest haplotype F1 (low basal CRP) and F3 (high basal CRP). F2 appears associated with intermediate basal CRP, while F4 and F5 are also associated with higher CRP (this is of borderline significance for F4 but not significant for F5, presumably because of the small numbers in this group). During haplotype inference, it was noted that the sixth and seventh commonest haplotypes (present on 2.5 and 1.8% of chromosomes, respectively) shared considerable sequence homology with F1, and could be assigned to the F1 clade (Figures 1 and 2) . Neither of these haplotypes, individually or combined, was common enough to draw any significant conclusions; however, we did find that the H6/H7 group was associated with a similar, low, bcoefficient to F1 (compared to F3: b ¼ À0.564, s.e. ¼ 0.371, t ¼ À1.369, P ¼ 0.173), suggesting they are likely to be genuinely 'low-producing' haplotypes.
Trans-acting effects on basal CRP expression
We evaluated trans-acting effects from three genes, APOE, IL1B and IL6, which are potentially associated with basal CRP expression. Once again, age, sex and SLE affection were included as standard covariates. Because we suspected that the dominant genetic effect on basal CRP arose from variation at CRP itself, we also included In an initial analysis, we assumed that the derived apolipoprotein E (ApoE) serotypes acted in an additive manner on basal CRP expression. Table 4 shows regression parameters for this model, with increasing copies of the rarer e2 or e4 type modelled by reference to the common e3 type. The trend was towards a higher basal CRP in carriers of e2 and a lower basal CRP in carriers of e4, although this was not significant. We also investigated the possibility that ApoE types acted in a recessive manner. In this model, a highly significant effect on basal CRP was seen in individuals with e2 e2 type. This remained significant at the Po0.05 level even after applying a conservative Bonferroni correction for six tests (three ApoE types each tested in additive and recessive models). Using these regression parameters, we could predict that an unaffected 30-year-old woman, homozygous for the common allele of rs3093077, would have a basal CRP of 2.86 mg l À1 if she carried the e2 e2 ApoE type, compared with 1.56 mg l À1 if she carried any other combination of ApoE type.
Each IL1B and IL6 SNP was examined for its effect on basal CRP and we also assessed for interaction between genotype and SLE. CRP levels were marginally higher in patients with SLE compared with their relatives. Although our cohort was restricted to individuals with a basal range CRP, we felt that a low-grade acute-phase response may underlie this difference. Since, presumably, IL1B and IL6 polymorphism influences CRP through an effect on interleukin-1b or -6 levels, respectively, we were interested in examining any potential genotype-disease interaction. No significant association was seen between genotype at any IL1B SNP and basal CRP. We also failed to observe an association between IL6 genotype and basal CRP in the cohort as a whole, but a weakly significant interaction between SLE and genotype at rs1800796 was observed (data shown in Table 3 ). This interaction was such that, in unaffected individuals, the rare allele of rs1800796 was associated with higher basal CRP, while in SLE patients no such effect was observed, and indeed the rare allele of rs1800796 appeared to have a negative effect (although not significant) on basal CRP.
Both the highly significant Apo e2 recessive effect and the weak rs1800796 interaction were included as covariates in the full CRP SNP and haplotype analyses presented in the first section of these results. Parameter estimates for these covariates included in the full model are also shown in Table 4 .
Discussion
In this paper, we explored the relationship between genotype and basal CRP in a cohort of Filipino SLE families. It was not our intention to re-examine the association between CRP genotype and disease. This has been reported elsewhere, and we had insufficient power to replicate these findings. 16, 27 Instead, we aimed to explore the genetic architecture of CRP in this previously unstudied Filipino population, with the intention of identifying novel haplotypes that aid the identification of functional SNPs or to utilize differences in population allele frequency to identify new associations. We were particularly interested in combining a CRP analysis with analysis of trans-acting loci reported to influence basal CRP, but not previously included as covariates in larger CRP studies. We are aware that our choice of cohort for addressing such questions on a population basis could be questioned, in particular, whether we are truly observing a 'basal' CRP in the SLE probands. We would argue that evidence for CRP dysregulation suggests a blunted acute-phase CRP, but studies of SLE patients with basal range CRP suggest normal levels and a preserved link with cardiovascular disease. 12 The argument that basal CRP in the SLE probands is influenced by low-grade inflammation is one that could also be applied to CRP studies proposing an inflammatory aetiology for cardiovascular disease, and perhaps only serves to highlight doubt over the functional significance of the 10 mg l À1 cutoff typically used to define basal CRP. 1 We have attempted to control for this by the inclusion of an SLE term in all models. At the very least our findings are relevant in the direct context of SLE families. Existing analyses have provided a picture of how haplotypes at CRP relate to basal CRP in Caucasian populations. [13] [14] [15] [16] Beyond this, the relationship between CRP polymorphism and basal CRP remains inconclusive. SNPs tagging each of the high and low CRP-associated haplotypes (including the commonly studied rs1205, rs1800947 and rs3091244) have all been 'significantly' associated with basal CRP in at least one study, but none have been associated in each study where they have been tested. [13] [14] [15] [16] 24, [28] [29] [30] It is difficult to directly compare haplotypes between populations unless one can be sure that all variation has been captured; nonetheless, the Filipino haplotypes appear similar to those found in Caucasians over the SNPs that have been typed in common. The lower section of Table 2 demonstrates Caucasian haplotypes from one of these published analyses to aid comparison. Haplotype F1 was associated with low basal CRP expression, and this has also been universally found for the equivalent Caucasian haplotype. Haplotype F3 was associated with high basal CRP expression. This has generally also been shown for the Caucasian equivalent, although the low frequency may Filipino CRP genetics B Rhodes et al limit the power to detect association. The Caucasian equivalent to F5 is universally associated with high basal CRP. F5 itself was also associated with higher CRP, although we were unable to show this significantly, presumably because it is rare and we lack adequate power. Haplotypes F6 and F7 are even less common in Caucasian populations and no CRP trend has been observed. We lacked adequate power to show a significant effect, although the regression parameters suggested an association with lower basal CRP. It is notable that the significance and magnitude of SNP effect increased along the F1/F6/F7 clade from rs1205/ rs7553007 to rs17860488/rs2027471, perhaps narrowing the number of potentially functional SNPs on this clade to rs17860488 or rs2027471 themselves or untyped SNPs in strong LD with them. There is some functional evidence for SNP rs3091244 from in vitro promoter experiments and electrophoretic mobility shift assays. 13, 31 Our findings support functionality for this SNP; however, we would argue that this is unlikely to be the sole functional polymorphism, otherwise we would predict equally low basal CRPs associated with F1 and F2 (both of which carry the rs3091244 'C' allele).
The association of haplotype F4 and its unique SNP, rs1800947, with basal CRP was interesting. Existing studies typically find an association between low basal CRP and the rare 'C' allele of rs1800947 along with the haplotype it defines (although a single study shows an opposite association with high basal CRP). 14, 15, 28, 29 In the Filipino population, rs1800947 'C' and haplotype F4 were almost twice as common as their Caucasian equivalents, and we therefore had greater power to detect an association. We found F4 to be associated with higher basal CRP than F1 (P ¼ 0.049) and this prompted us to reanalyse our single SNP data, proposing a functional role for rs1800947. By modelling rs1800947 as an independent covariate, the significance of all the associated SNPs increases, supporting this hypothesis. Phylogenetically, this is also feasible if, as we propose, haplotype F4 forms a distinct clade diverging from ancestral F1 independently of all the other haplotypes. There are a number of explanations why this effect is not commonly observed in the Caucasian cohorts. It is possible that rs1800947 'C' is in LD with a true functional SNP in Filipinos but not in Caucasians: sequencing these haplotypes may be required to demonstrate this. In both Caucasian and Filipinos, rs1800947 'C' is always found in association with the rs1205 'A' allele and other SNPs in strong LD with rs1205. Therefore, an alternative explanation is that rs1800947 is truly functional, but in Caucasians, where it is less frequent (approximate reported frequency 5-6%), its effect is swamped by an opposite functional effect arising on the rs1205 'A' clade. In contrast in Filipinos where we observed rs1800947 at higher frequency (12%), we have greater power to observe an independent functional effect.
The association between structural variants of ApoE and basal CRP are reported elsewhere. In general, the e4 variant has been associated with lower basal CRP than the e3 variant. 17, 22 The e2 variant is rare in Caucasians and no significant effect has been reported in this group. In Oriental populations, e2 is more common and a study in Japanese Americans has shown a significant association with higher CRP. 7 Apo e2 was considerably more common in our Filipino cohort and we also demonstrated a clear e2 effect. The likely scenario is that ApoE type has a graded effect on basal CRP, with e4 and e2 at the high and low extremes. The mechanism underlying the link between Apolipoprotein E type and basal CRP has yet to be established, but our findings show that functional explanations limited to Apo e4 are inadequate. The association of basal CRP with IL1B and IL6 polymorphism has also been described elsewhere. 4, 18, 21, [23] [24] [25] [26] It could be argued that, by definition, 'basal CRP' (that is, o10 mg l À1 ) should not be determined by acute-phase cytokines; however, we feel that this is far from clear, and indeed inflammatory explanations have been proposed to explain the link between basal CRP and cardiovascular disease. Our finding of an effect from IL6 genotype on CRP within this basal range CRP emphasizes this point. We have also demonstrated an effect from this IL6 SNP in a different Caucasian cohort (data in submission), although a direct comparison of the two groups is difficult because of marked differences in allele frequency and patterns of LD. Nonetheless, a consistent association between basal CRP and IL6 polymorphism has important implications. Future work in 'basal' CRP cohorts and further fine mapping is required to fully delineate the genetic effect.
Basal CRP has promise as a biomarker for cardiovascular disease, and the search for genetic variants influencing its expression is of great importance. With the realization that SNP and haplotype frequencies vary considerably between ethnic groups, the study of nonCaucasian populations may help clarify some ambiguity in the existing literature. In this Filipino cohort, the different haplotype frequencies in comparison with Caucasian populations has allowed us to re-confirm with increased certainty a series of SNPs and haplotypes associated with basal CRP variation. We have postulated an independent genetic effect from rs1800947, while novel, low frequency haplotypes apparently associated with low CRP production have allowed us to narrow down potentially functional SNPs (in particular, away from the much published rs1205). The association between basal CRP and Apo e2 is stronger than previously reported and emphasizes the importance of APOE as a trans-acting locus. Published CRP genetic analyses in Caucasians have only explained o3% total basal CRP variation. 14, 28, 29 This study demonstrates that a profile of genetic variants, both at CRP itself and at transacting loci will be needed to fully explain the genetic component of basal CRP variation. Identifying this profile will improve the use of basal CRP as a predictor for cardiovascular risk, and increase our power to detect associations between CRP variation and disease. 33 Although Filipinos are a distinct ethnic group, they are more closely related to the Han Chinese than any of the other HapMap populations. 34 Second, we included all SNPs tagging the HapMap CEPH panel and also all SNPs with any existing published data. The [AT/À] polymorphism was included as it was novel at the time of project design. The resulting selected SNPs also provided reasonably uniform physical coverage across CRP (Figure 1 ). The most intensively studied regions of IL6 are the promoter and 5 0 flank regions, in particular, SNPs rs1800795 and rs1800796. In the HapMap CHB panel, SNPs in these regions are in weak LD with no clear haplotypes. A similar situation is seen at IL1B. For these genes, we therefore selected five SNPs that had appeared in previously published work, rather than adopting a tagging approach. Apolipoprotein E serotype is determined by the presence of alleles at two APOE SNPs, rs429358 and rs7412; both were genotyped. The e2, e3 and e4 serotypes were inferred from the genotype data, with the rare allele of rs429358 determining the e4 type and the rare allele of rs7412 determining the e2 type. It was assumed that the minor alleles of these two SNPs never appeared on the same haplotype; an approach that has been taken and validated elsewhere. 22 All polymorphisms are referred to throughout this paper by their dbSNP database rs number (http:// www.ncbi.nlm.nih.gov/projects/SNP/). Genotyping was by Matrix-Assisted Laser Desorption and Ionization-Time Of Flight (MALDI-TOF) mass spectrometry (Sequenom, Hamburg, Germany). 35 Primer designs are available on request. Twelve SNPs were excluded from further analysis as they had a minor allele frequency o2% (rs16842484, rs12744244, rs2027469, rs876538, rs3093066, rs3093063, rs3093062, rs3093061, rs3093058, rs1800795, rs1554606, rs7596461 and rs1143634). SNP rs11265257 was excluded as it was genotyped in o90% of individuals. Two whole families and seven additional siblings were excluded as they showed evidence of expaternity (Mendelian inconsistency at 410% markers on Pedcheck). 36 Two individuals were excluded as successfully genotyped at o75% markers.
Patients and methods

Study cohort
CRP quantification C-reactive protein quantification was performed using automated latex-enhanced immunoturbimetry on an Olympus AU2700 analyser (Olympus Diagnostics, Southall, UK), which quantifies CRP accurate to 0.01 mg l 
Statistical analysis
Data were stored and managed using BC/GENE v2.2.5 software (Biocomputing Platforms Ltd, Espoo, Finland). The CRP distribution was positively skewed so a natural log-transformation was taken for all analyses. Regression models to evaluate SNP and haplotype association were constructed in SPSS v14. Population haplotype structure was estimated from the unrelated founders using Haploview and the algorithm of Gabriel et al. 33, 37 Haplotype clade analysis was performed using TCS: phylogenetic network association using statistical parsimony v1.21, with default settings applied. 38 Assignment of phased haplotypes to each individual was performed initially using PHASE v2.1.
39,40 PHASE potentially overestimates rare haplotypes in clustered family data, so when genotype data were available on more than one individual in a family, we cross-checked haplotype assignment using MERLIN, which infers haplotypes on the basis of patterns of gene flow. 41 No discrepancies between the two techniques were identified.
